miR-937-5p targets SOX17 to modulate breast cancer cell cycle and cell proliferation through the Wnt signaling pathway

Xiang Xiong,Wendi Xu,Jia Gong,Liwen Wang,Mei Dai,Gannong Chen,Liqin Yuan

DOI: https://doi.org/10.1016/j.cellsig.2020.109818

IF: 4.85

2021-01-01

Cellular Signalling

Abstract:<p>Breast cancer is one of the most frequent cancers in women and the globally leading cause of cancer-related deaths. Bioinformatics and experimental analyses found that miR-937-5p may play a proto-oncogenic role in breast cancer; however, the specific effects and the molecular mechanism need further investigation. GSEA-KEGG and GSEA-GO suggested that miR-937-5p might be related to cell cycle and DNA replication. The experimental data indicated that miR-937-5p inhibition significantly repressed the proliferation of breast carcinoma cells and elicited S-phase cell cycle arrest. Meanwhile, the protein levels of proliferating marker ki-67 and cell cycle regulators Cyclin A2, Cyclin B1, CDK1, and Cyclin D1 were also decreased by miR-937-5p inhibition. miR-937-5p could directly bind to and negatively regulate SOX17. SOX17 overexpression also significantly repressed the proliferation of breast carcinoma cells and elicited S-phase cell cycle arrest and decreased ki-67, β-catenin, c-Myc, Cyclin A2, Cyclin B1, Cyclin D1, and CDK1 protein contents. More importantly, the effects of miR-937-5p were reversed by SOX17.</p>

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of miR - 937 - 5p in the breast cancer cell cycle and cell proliferation and its molecular mechanism. Specifically, the researchers experimentally verified whether miR - 937 - 5p regulates the cell cycle and proliferation of breast cancer cells by targeting SOX17, and further explored whether this process is achieved through the Wnt signaling pathway.

### Research Background
- **Breast Cancer**: Breast cancer is one of the most common cancers among women and is also one of the leading causes of cancer - related deaths worldwide.
- **miR - 937 - 5p**: Preliminary bioinformatics and experimental analyses indicate that miR - 937 - 5p may play a carcinogenic role in breast cancer, but its specific effects and molecular mechanisms need further study.
- **SOX17**: SOX17 is a known antagonist of the Wnt/β - catenin signaling pathway and may be related to the regulation of miR - 937 - 5p.

### Research Objectives
1. **Verify the expression level of miR - 937 - 5p in breast cancer**: Through the detection of clinical samples and cell lines, confirm the abnormally high expression of miR - 937 - 5p in breast cancer.
2. **Explore the influence of miR - 937 - 5p on the breast cancer cell cycle and proliferation**: By inhibiting miR - 937 - 5p, observe its inhibitory effect on the cell cycle and proliferation.
3. **Determine the downstream targets of miR - 937 - 5p**: Through bioinformatics analysis and experimental verification, determine whether miR - 937 - 5p directly targets SOX17.
4. **Explore the mechanism of action of miR - 937 - 5p through the Wnt signaling pathway**: By over - expressing or knocking down SOX17, verify its influence on the activity of the Wnt signaling pathway and the cell cycle.

### Main Findings
- **High expression of miR - 937 - 5p in breast cancer**: In clinical samples and cell lines, the expression level of miR - 937 - 5p is significantly higher than that in normal tissues.
- **Effect of miR - 937 - 5p inhibition on the cell cycle and proliferation**: Inhibiting miR - 937 - 5p can significantly inhibit the proliferation of breast cancer cells and lead to S - phase cell cycle arrest.
- **miR - 937 - 5p directly targets SOX17**: Through the dual - luciferase reporter gene experiment, it was confirmed that miR - 937 - 5p can directly bind to and negatively regulate the expression of SOX17.
- **Effect of SOX17 on the Wnt signaling pathway and the cell cycle**: Over - expressing SOX17 can significantly inhibit the activity of the Wnt signaling pathway, leading to cell cycle arrest and a decrease in cell proliferation.
- **miR - 937 - 5p exerts its effect through SOX17**: By simultaneously inhibiting miR - 937 - 5p and knocking down SOX17, it was verified that the effect of miR - 937 - 5p can be reversed by the expression of SOX17.

### Conclusion
This study reveals the molecular mechanism by which miR - 937 - 5p regulates the breast cancer cell cycle and proliferation by targeting SOX17 and then through the Wnt signaling pathway. These findings provide a new perspective for understanding the pathogenesis of breast cancer and may provide potential targets for the development of new treatment strategies.